3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Arthritis, Rheumatoid
10
Psoriasis
6
Leukemia
5
Lymphoma, Follicular
4
Myelodysplastic Syndromes
3
Inflammation
3
Asthma
3
Arthritis, Juvenile
3
Vasculitis
2
Uveitis
2
Respiratory Distress Syndrome
2
Recurrence
2
Prostatic Neoplasms
2
Pneumonia
2
Neuroblastoma
2
Neoplasms
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Granulomatosis with Polyangiitis
2
Bronchiolitis Obliterans
2
Wilms Tumor
1
Temporomandibular Joint Disorders
1
Stomatitis
1
Spondylitis, Ankylosing
1
Spondylarthritis
1
Pruritus
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Plaque, Amyloid
1
Interventions
telitacicept
3
fludarabine
3
Prednisone
3
Cyclophosphamide
3
Specimen Handling
2
Nivolumab
2
Antilymphocyte Serum
2
thymoglobulin
1
remdesivir
1
prednylidene
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
cabozantinib
1
Vitamin D
1
Valsartan
1
Pyridostigmine Bromide
1
Population Groups
1
Platinum Compounds
1
Plasma Exchange
1
Peripheral Blood Stem Cell Transplantation
1
Music Therapy
1
Melphalan
1
Ipilimumab
1
Infliximab
1
Immunoglobulins, Intravenous
1
Hydroxychloroquine
1
Fish Oils
1
Fatty Acids, Omega-3
1
Etoposide
1
Etanercept
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Autoimmune Diseases
×
Etanercept
×
Clear all
NCT01793519
2024-02-28
STARA
Georgetown University
Phase 4
Unknown
290 enrolled